Affiliation:
1. Department of Medical Biology, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey
Abstract
Introduction:
Toll-like receptor 4 (TLR4) is a receptor that traditionally plays an important
role in immunomodulation (regulation of the immune system) and the initiation of proinflammatory
responses. TLR4 is used in the body to recognize molecular patterns of pathogens or
damaged cells from outside. However, in recent years, it has also become clear that TLR4 can affect
the immune system and the function of stem cells, especially mesenchymal stem cells. Therefore,
understanding how TLR4 signaling works at the cellular and molecular level and using this
knowledge in regenerative medicine could be potentially useful, especially in the treatment of adipose-
derived mesenchymal stem cells (ADMSCs). How these cells can use TLR4 signaling when
used to increase their regenerative potential and repair tissues is an area of research.
Aims:
This study aims to elucidate the multifaceted role of TLR4-mediated signaling in ADMSCs.
Methods:
Employing a comprehensive set of assays, including MTT for cell viability, flow cytometry
for surface marker expression, and gene expression analysis, we demonstrate that TLR4
activation significantly modulates key aspects of ADMSC biology. Specifically, TLR4 signaling
was found to regulate ADMSCs proliferation, surface marker expression, and regenerative capacity
in a dose- and time-dependent manner. Furthermore, TLR4 activation conferred cytoprotective
effects against Doxorubicin (DOX)-induced cellular apoptosis.
Results:
These findings suggest that TLR4 signaling could be used to enhance the regenerative
abilities of ADMSCs and enable ADMSC-based therapies to be used more effectively for tissue
engineering and therapeutic purposes.
Conclusion:
However, it is important to note that research in this area needs more details and clinical
studies.
Publisher
Bentham Science Publishers Ltd.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献